Evidence map›Paper›PMID 35740373›Full record

ArticleBiomedicines2022

High Level Expression and Purification of Cecropin-like Antimicrobial Peptides in

Chih-Lung Wu, Ya-Han Chih, Hsin-Ying Hsieh, Kuang-Li Peng, Yi-Zong Lee, Bak-Sau Yip, Shih-Che Sue, Jya-Wei Cheng

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chih-Lung WuDepartment of Medical Science, Institute of Biotechnology, National Tsing Hua University, Hsinchu 300, Taiwan.
Ya-Han ChihDepartment of Medical Science, Institute of Biotechnology, National Tsing Hua University, Hsinchu 300, Taiwan.
Hsin-Ying HsiehDepartment of Medical Science, Institute of Biotechnology, National Tsing Hua University, Hsinchu 300, Taiwan.
Kuang-Li PengDepartment of Medical Science, Institute of Biotechnology, National Tsing Hua University, Hsinchu 300, Taiwan.
Yi-Zong LeeInstitute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu 300, Taiwan.
Bak-Sau YipDepartment of Medical Science, Institute of Biotechnology, National Tsing Hua University, Hsinchu 300, Taiwan.
Shih-Che SueInstitute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu 300, Taiwan.ORCID 0000-0002-2169-0157
Jya-Wei ChengDepartment of Medical Science, Institute of Biotechnology, National Tsing Hua University, Hsinchu 300, Taiwan.ORCID 0000-0003-3331-691X
National Tsing Hua University · TW

Funding

Ministry of Science and Technology, Taiwan 110-2113-M-007-021
6 · The paper itself

Abstract

Cecropins are a family of antimicrobial peptides (AMPs) that are widely found in the innate immune system of Cecropia moths. Cecropins exhibit a broad spectrum of antimicrobial and anticancer activities. The structures of Cecropins are composed of 34-39 amino acids with an N-terminal amphipathic α-helix, an AGP hinge and a hydrophobic C-terminal α-helix. KR12AGPWR6 was designed based on the Cecropin-like structural feature. In addition to its antimicrobial activities, KR12AGPWR6 also possesses enhanced salt resistance, antiendotoxin and anticancer properties. Herein, we have developed a strategy to produce recombinant KR12AGPWR6 through a salt-sensitive, pH and temperature dependent intein self-cleavage system. The His6-Intein-KR12AGPWR6 was expressed by

Indexed as

antimicrobial peptidececropin-likeexpressioninteinself-cleavage

Identifiers

PMID35740373
PMCPMC9220022
OpenAlexW4281943491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.